Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Ovarian Neoplasms

Free Subscription Articles published in Nat Med Retrieve available abstracts of 6 articles: HTML format

Single Articles

January 2025
1. CHRISTIANSEN F, Konuk E, Ganeshan AR, Welch R, et al
   International multicenter validation of AI-driven ultrasound detection of ovarian cancer.
   Nat Med. 2025 Jan 2. doi: 10.1038/s41591-024-03329.
   PubMed     Abstract available
   
   
   June 2024
2. JIANG R, Feng Y, Chen Y, Cheng X, et al
   Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial.
   Nat Med. 2024 Jun 1. doi: 10.1038/s41591-024-02981.
   PubMed     Abstract available
   
   
   May 2024
3. WU X, Liu J, Wang J, Wang L, et al
   Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial.
   Nat Med. 2024 May 15. doi: 10.1038/s41591-024-03003.
   PubMed     Abstract available
   
   
   
4. FRIEDMAN CF, Manning-Geist BL, Zhou Q, Soumerai T, et al
   Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
   Nat Med. 2024;30:1330-1338.
   PubMed     Abstract available
   
   
   January 2024
5. AMGAD M, Hodge JM, Elsebaie MAT, Bodelon C, et al
   A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer.
   Nat Med. 2024;30:85-97.
   PubMed     Abstract available
   
   
   June 2023
6. YAP TA, Fontana E, Lee EK, Spigel DR, et al
   Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
   Nat Med. 2023;29:1400-1411.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum